Key facts
- It has raised $151.8M across 2 recorded rounds; the latest was Early Stage VC ($16.7M) in Nov 2023.
- Notable investors include Bhupendra Modi, EOS Ventures, Eos Venture Partners, Newcross Healthcare, Nimble Portal — 7 tracked in total.
- Fountain Life has filed 4 Form Ds with the SEC since 2023, most recently Mar 2025 ($16.7M sold to 26 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Fountain Life
Funding rounds
2 roundsAbout Fountain Life
Provider of healthcare services intended to provide predictive, preventative, personalized and data-driven healthcare to patients. The company leverages science and technologies globally to provide effective and affordable treatments to enhance the health span, performance and vitality of individuals, enabling patients to get access to personalized healthcare in a simplified way.
- Sector
- Healthcare
- HQ
- Orlando, FL, United States
- Founded
- 2019
- Employees
- 192
- Website
- fountainlife.com/
- Ownership
- Privately Held (backing)
Fountain Life doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fountain Life shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fountain Life in its N-PORT filings yet. We sweep new filings monthly.